Molecular Approach in Control of Cell Death in Embryonic Stem Cell Differentiation

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 500

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

NSCMRMED03_038

تاریخ نمایه سازی: 30 دی 1397

Abstract:

We aimed to investigate whether mitochondrial apoptosis andspecification employ a common pathway due to various evidence thatindicates that the differentiation and apoptosis might share commonfeatures. Split luciferase complementary assay showed that delay inapoptosome complex formation contributes to mouse embryonic stemcells cardiogenic differentiation. The contribution of apoptosis hallmarksto human embryonic stem cells (hESCs) cardiogenic differentiationhas also shown. Our results indicate the involvement of delayedmitochondrial apoptotic pathway as well as reversible mitochondrialouter layer disintegration in cardiogenic differentiation. We have alsofound that upon moderate doxorubicin apoptosis induction, hESCshowed differentiation hallmarks. Further investigation showed that lowlevel of Apaf-1 expression during early stages of neural differentiation canbe considered as a possible regulatory barrier by which differentiatingcells control cell death upon a rise in ROS (reactive oxygen species)elevation and cytochrome c release from mitochondria. We will showhow molecular approach in control of cell death can support humanembryonic stem cells during differentiation.

Authors

Saman Hosseinkhani

Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Parisa Ghiasi

Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Shiva Akbari-birgani

Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran

Hossein Baharvand

Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology andTechnology, ACECR, Tehran, Iran